SEARCH

SEARCH BY CITATION

References

  • Berman S. B., Zigmond M. J. and Hastings T. G. (1996) Modification of dopamine transporter function: effect of reactive oxygen species and dopamine. J. Neurochem. 67, 593600.
  • Binda F., Dipace C., Bowton E. et al. (2008) Syntaxin 1A interaction with the dopamine transporter promotes amphetamine-induced dopamine efflux. Mol. Pharmacol. 74, 11011108.
  • Boudanova E., Navaroli D. M. and Melikian H. E. (2008) Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent. Neuropharmacology 54, 605612.
  • Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248254.
  • Chen R., Furman C. A., Zhang M., Kim M. N., Gereau R. W. T., Leitges M. and Gnegy M. E. (2009) Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice. J. Pharmacol. Exp. Ther. 328, 912920.
  • Chu P. W., Seferian K. S., Birdsall E., Truong J. G., Riordan J. A., Metcalf C. S., Hanson G. R. and Fleckenstein A. E. (2008) Differential regional effects of methamphetamine on dopamine transport. Eur. J. Pharmacol. 590, 105110.
  • Clausing P., Gough B., Holson R. R., Slikker Jr W. and Bowyer J. F. (1995) Amphetamine levels in brain microdialysate, caudate/putamen, substantia nigra and plasma after dosage that produces either behavioral or neurotoxic effects. J. Pharmacol. Exp. Ther. 274, 614621.
  • Connor C. E. and Kuczenski R. (1986) Evidence that amphetamine and Na+ gradient reversal increase striatal synaptosomal dopamine synthesis through carrier-mediated efflux of dopamine. Biochem. Pharmacol. 35(312), 33130.
  • Fleckenstein A. E., Metzger R. R., Beyeler M. L., Gibb J. W. and Hanson G. R. (1997a) Oxygen radicals diminish dopamine transporter function in rat striatum. Eur. J. Pharmacol. 334, 111114.
  • Fleckenstein A. E., Metzger R. R., Wilkins D. G., Gibb J. W. and Hanson G. R. (1997b) Rapid and reversible effects of methamphetamine on dopamine transporters. J. Pharmacol. Exp. Ther. 282, 834838.
  • Fleckenstein A. E., Volz T. J., Riddle E. L., Gibb J. W. and Hanson G. R. (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681698.
  • Fog J. U., Khoshbouei H., Holy M. et al. (2006) Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 51, 417429.
  • Foster J. D., Adkins S. D., Lever J. R. and Vaughan R. A. (2008) Phorbol ester induced trafficking-independent regulation and enhanced phosphorylation of the dopamine transporter associated with membrane rafts and cholesterol. J. Neurochem. 105, 16831699.
  • Fumagalli F., Gainetdinov R. R., Valenzano K. J. and Caron M. G. (1998) Role of dopamine transporter in methamphetamine-induced neurotoxicity: evidence from mice lacking the transporter. J. Neurosci. 18, 48614869.
  • Granado N., Ares-Santos S., Oliva I., O’Shea E., Martin E. D., Colado M. I. and Moratalla R. (2011) Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA. Neurobiol. Dis. 42, 391403.
  • Hadlock G. C., Baucum II A. J., King J. L., Horner K. A., Cook G. A., Gibb J. W., Wilkins D. G., Hanson G. R. and Fleckenstein A. E. (2009) Mechanisms underlying methamphetamine-induced dopamine transporter complex formation. J. Pharmacol. Exp. Ther. 329, 169174.
  • Hadlock G. C., Chu P. W., Walters E. T., Hanson G. R. and Fleckenstein A. E. (2010) Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation. J. Pharmacol. Exp. Ther. 335, 207212.
  • Johnson L. A., Furman C. A., Zhang M., Guptaroy B. and Gnegy M. E. (2005a) Rapid delivery of the dopamine transporter to the plasmalemmal membrane upon amphetamine stimulation. Neuropharmacology 49, 750758.
  • Johnson L. A., Guptaroy B., Lund D., Shamban S. and Gnegy M. E. (2005b) Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta. J. Biol. Chem. 280, 1091410919.
  • Kahlig K. M., Binda F., Khoshbouei H., Blakely R. D., McMahon D. G., Javitch J. A. and Galli A. (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc. Nat Acad. Sci. USA 102, 34953500.
  • Kokoshka J. M., Metzger R. R., Wilkins D. G., Gibb J. W., Hanson G. R. and Fleckenstein A. E. (1998) Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain. Brain Res. 799, 7883.
  • LaVoie M. J. and Hastings T. G. (1999) Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 14841491.
  • Mack F. and Bonisch H. (1979) Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch. Pharmacol. 310, 19.
  • Mark K. A., Soghomonian J. J. and Yamamoto B. K. (2004) High-dose methamphetamine acutely activates the striatonigral pathway to increase striatal glutamate and mediate long-term dopamine toxicity. J. Neurosci. 24, 1144911456.
  • Melikian H. E. and Buckley K. M. (1999) Membrane trafficking regulates the activity of the human dopamine transporter. J. Neurosci. 19, 76997710.
  • Metzger R. R., Haughey H. M., Wilkins D. G., Gibb J. W., Hanson G. R. and Fleckenstein A. E. (2000) Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia. J. Pharmacol. Exp. Ther. 295, 10771085.
  • Rao A., Simmons D. and Sorkin A. (2010) Differential subcellular distribution of endosomal compartments and the dopamine transporter in dopaminergic neurons. Mol. Cell. Neurosci. 46, 148158.
  • Richards T. L. and Zahniser N. R. (2009) Rapid substrate-induced down-regulation in function and surface localization of dopamine transporters: rat dorsal striatum versus nucleus accumbens. J. Neurochem. 108, 15751584.
  • Robertson S. D., Matthies H. J. and Galli A. (2009) A closer look at amphetamine-induced reverse transport and trafficking of the dopamine and norepinephrine transporters. Mol. Neurobiol. 39, 7380.
  • Sandoval V., Riddle E. L., Ugarte Y. V., Hanson G. R. and Fleckenstein A. E. (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J. Neurosci. 21, 14131419.
  • Saunders C., Ferrer J. V., Shi L. et al. (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc. Nat Acad. Sci. USA 97, 68506855.
  • Sorkina T., Hoover B. R., Zahniser N. R. and Sorkin A. (2005) Constitutive and protein kinase C-induced internalization of the dopamine transporter is mediated by a clathrin-dependent mechanism. Traffic 6, 157170.
  • Sulzer D. and Rayport S. (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron, 5, 797808.
  • Vaughan R. A., Huff R. A., Uhl G. R. and Kuhar M. J. (1997) Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J. Biol. Chem. 272, 1554115546.
  • Xu M., Chandler L. J. and Woodward J. J. (2008) Ethanol inhibition of recombinant NMDA receptors is not altered by coexpression of CaMKII-alpha or CaMKII-beta. Alcohol 42, 425432.
  • Zhou Q. Y., Grandy D. K., Thambi L. et al. (1990) Cloning and expression of human and rat D1 dopamine receptors. Nature 347, 7680.